Elicio Therapeutics (ELTX) Interest Coverage Ratio (2022 - 2026)
Elicio Therapeutics (ELTX) reported Interest Coverage Ratio of 26.05 for Q1 2026, up 57.3% on a YoY basis from 16.56 in Q1 2025, and up 0.72% quarter-over-quarter from 26.24 in Q4 2025.
Elicio Therapeutics (ELTX) Interest Coverage Ratio (2022 - 2026) Analysis & Trends
Elicio Therapeutics has reported Interest Coverage Ratio for 5 years, with the latest figure at 26.05 in Q1 2026.
- For the quarter ending Q1 2026, Interest Coverage Ratio rose 57.3% year-over-year to 26.05; the trailing twelve-month figure through Mar 2026 stood at 27.55 (up 63.89% YoY), and the FY2025 full-year result was 33.29, up 66.33% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 26.05, up from 26.24 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 5.35 in Q3 2022, with the low at 10771.0 in Q3 2023.
- Historically, Interest Coverage Ratio has averaged 1025.09 across 5 years, with a median of 54.8 in 2024.
- Annual changes were most pronounced in 2023 — Interest Coverage Ratio plunged 201132.89% — and 2024, when it soared 99.3%.
- Elicio Therapeutics' Interest Coverage Ratio stood at 64.79 in 2022, then plunged by 7147.64% to 4696.0 in 2023, then soared by 98.77% to 57.59 in 2024, then soared by 54.44% to 26.24 in 2025, then gained by 0.72% to 26.05 in 2026.
- The last three Interest Coverage Ratio figures came in at 26.05 (Q1 2026), 26.24 (Q4 2025), and 18.88 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Elicio Therapeutics | 70.12 Mn | 55.17 Mn | - | -26.05 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.05 |
| Dec 31, 2025 | -26.24 |
| Sep 30, 2025 | -18.88 |
| Jun 30, 2025 | -52.02 |
| Mar 31, 2025 | -61.00 |
| Dec 31, 2024 | -57.59 |
| Sep 30, 2024 | -75.50 |
| Jun 30, 2024 | -222.94 |
| Mar 31, 2024 | -284.47 |
| Dec 31, 2023 | -4,696.00 |
| Sep 30, 2023 | -10,771.00 |
| Jun 30, 2023 | -10.89 |
| Mar 31, 2023 | -22.82 |
| Dec 31, 2022 | -64.79 |
| Sep 30, 2022 | -5.35 |
| Jun 30, 2022 | -5.84 |